Literature DB >> 19320383

[Flexible fiberoptic in-office laryngeal biopsy].

Jacob T Cohen1, Dan M Fliss.   

Abstract

In-office flexible transnasal Laryngeal biopsy is a reliable safe and easy to perform diagnostic procedure. We present a review of thirty procedures on twenty nine patients presented at our voice and swallowing clinic during the period March 2006 to January 2007. The mean age was 70 years (range 48 to 86 years). Twenty-six patients (89% had co-morbidities such as: ischemic heart disease, congestive heart failure, cerebrovascular disease and neurologicaL disorders. In 17 (57%) cases, the in-office transnasal laryngeal biopsy results saved the necessity to take the patient to the operating suite for diagnosis and was the only invasive intervention before recommendations of treatment were made. Out of 16 patients with Lesions suspected of being malignant, 82% were diagnosed as suffering from squamous cell carcinoma of the vocal cords. The time between referral of the patient and biopsy was short compared to the time needed to prepare patients to undergo biopsy under general anesthesia. There were no significant complications in this series. According to the authors' opinion, Laryngeal diagnostic procedures performed in the office with local anesthesia will replace the need for direct laryngoscopy in the operating room conducted only in order to provide a biopsy, except in special cases.

Entities:  

Mesh:

Year:  2009        PMID: 19320383

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  2 in total

1.  Comparison of trans-nasal laryngoscopic office based biopsy of laryngopharyngeal lesions with traditional operative biopsy.

Authors:  Craig H Zalvan; Darnell J Brown; Stanley J Oiseth; Rick M Roark
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-26       Impact factor: 2.503

2.  Transnasal Flexible Fiberoptic in-office Laryngeal Biopsies-Our Experience with 117 Patients with Suspicious Lesions.

Authors:  Jacob T Cohen; Limor Benyamini
Journal:  Rambam Maimonides Med J       Date:  2014-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.